Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
Veronica Popescu(Hasselt University), Hugo Vrenken(Amsterdam Neuroscience), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Renee Xavier de Menezes(Amsterdam UMC Location VUmc), Frederik Barkhof(Netherlands Institute for Neuroscience), Adriaan Versteeg(Amsterdam Neuroscience), Menno M. Schoonheim(Amsterdam Neuroscience), Marianne A. Jonker(Amsterdam UMC Location VUmc), Francisca Gallindo Garre(Amsterdam UMC Location VUmc), Nimisha Chaturvedi(Amsterdam UMC Location VUmc)
Cited by 53
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k